Search results for "EDEMA"

showing 10 items of 625 documents

Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels

2016

Background Hereditary angioedema with normal C1 inhibitor levels (HAE-N) is associated with a Factor XII mutation in 30% of subjects; however, the role of this mutation in the pathogenesis of angioedema is unclear. Objective We sought evidence of abnormalities in the pathways of bradykinin formation and bradykinin degradation in the plasma of patients with HAE-N both with and without the mutation. Methods Bradykinin was added to plasma, and its rate of degradation was measured by using ELISA. Plasma autoactivation was assessed by using a chromogenic assay of kallikrein formation. Plasminogen activator inhibitors (PAIs) 1 and 2 were also measured by means of ELISA. Results PAI-1 levels varie…

0301 basic medicinemedicine.medical_specialtymedicine.medical_treatmentImmunologyBradykinin030204 cardiovascular system & hematologyArticleC1-inhibitor03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineFibrinolysismedicineImmunology and AllergyFactor XIIAngioedemabiologybusiness.industryKallikreinmedicine.disease030104 developmental biologyEndocrinologychemistryPlasminogen activator inhibitor-1Hereditary angioedemabiology.proteinmedicine.symptombusinessJournal of Allergy and Clinical Immunology
researchProduct

Cardiotoxicity and Cardioprotection by Artesunate in Larval Zebrafish

2019

Although artesunate (ART) is generally accepted as a safe and well-tolerated first-line treatment of severe malaria, cases of severe side effects and toxicity of this compound are also documented. This study applied larval zebrafishes to determine the acute toxicity and efficacy of ART and performed RNA-sequencing analyses to unravel the underlying signaling pathways contributing to ART’s activities. Results from acute toxicity assay showed that a single-dose intravenous injection of ART from 3.6 ng/fish (1/9 maximum nonlethal concentration) to 41.8 ng/fish (lethal dose 10%) obviously induced pericardial edema, circulation defects, yolk sac absorption delay, renal edema, and swim bladder l…

0301 basic medicinenatural productsHealth Toxicology and MutagenesisShort ReportmalariaDevelopmental toxicityPharmacologyToxicologyNephrotoxicity03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEdemamedicinecancernetwork pharmacologyCardiotoxicityChemical Health and Safetybusiness.industrylcsh:RM1-950Public Health Environmental and Occupational Healthmedicine.diseaseAcute toxicity030104 developmental biologylcsh:Therapeutics. PharmacologychemistryArtesunate030220 oncology & carcinogenesisHeart failureToxicitymedicine.symptombusinessDose-Response
researchProduct

[Management of patients with lymphatic diseases and lipoedema during the COVID-19 pandemic. Recommendations of the Spanish Group of Lymphology].

2020

Resumen La pandemia de COVID-19 es un desafío para el manejo de las patologías no COVID como la enfermedad linfática y el lipedema. La Telemedicina puede evitar la propagación del coronavirus. Se necesita un sistema que nos ayude a determinar la prioridad clínica y la selección de la asistencia presencial o telemática para cada paciente y la forma de realizarlas durante la pandemia. El Grupo Español de Linfología (GEL) ha realizado un documento de consenso con recomendaciones basadas en la bibliografía y experiencia clínica, como guía de práctica clínica en el manejo de anomalías linfáticas y lipedema durante la pandemia de COVID-19. Estas recomendaciones deben adaptarse a las característic…

030506 rehabilitationOffice VisitsDiseaseComorbidityLymphatic abnormality0302 clinical medicinevascularPandemicHealth caretriajePrecision MedicineRehabilitationDisease ManagementEquipment DesignContinuity of Patient CareTelemedicineClinical PracticeManual Lymphatic DrainageMedical emergency0305 other medical scienceCoronavirus InfectionstelemedicinaTelemedicineCoronavirus disease 2019 (COVID-19)Pneumonia Viralanomalía linfáticaPhysical Therapy Sports Therapy and RehabilitationArticle03 medical and health sciencesBetacoronavirusPatient Education as TopicCompression BandagesmedicineHumanslinfedemaanomalía vascularLymphatic DiseasesPandemicsPhysical Therapy Modalitiesmalformación vascularHealth Services Needs and Demandanomalía venosabusiness.industrySARS-CoV-2LipedemaLipoedemapandemiaCOVID-19medicine.diseaseTelephoneVideoconferencingEmergenciesPatient ParticipationTriagebusiness030217 neurology & neurosurgeryRehabilitacion
researchProduct

Widening use of dexamethasone implant for the treatment of macular edema

2017

Vincenza Bonfiglio, Michele Reibaldi, Matteo Fallico, Andrea Russo, Alessandra Pizzo, Stefano Fichera, Carlo Rapisarda, Iacopo Macchi, Teresio Avitabile, Antonio Longo Department of Ophthalmology, University of Catania, Catania, Italy Abstract: Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolymer to release the active ingredient within the vitreous chamber for up to 6 months after an intravitreal injection, allowing a prolonged interval of effica…

3003intravitrealgenetic structuresimplantmedicine.medical_treatmentPharmaceutical ScienceVitrectomyReviewDrug Implantcorticosteroids0302 clinical medicineGlucocorticoidCentral retinal vein occlusionDrug DiscoveryDelayed-Action PreparationCorticosteroidRandomized Controlled Trials as TopicDrug ImplantsCorticosteroids; Dexamethasone; Implant; Intravitreal; Macular edema; Pharmacology; 3003; Drug Discovery3003 Pharmaceutical ScienceDiabetic retinopathyIntravitreal InjectionsUveitismedicine.drugHumanmedicine.medical_specialtydexamethasone03 medical and health sciencesOphthalmologymedicineHumansMacular edemaGlucocorticoidsDexamethasonePharmacologyMacular edemaDiabetic Retinopathybusiness.industryIntravitreal InjectionDrug Discovery3003 Pharmaceutical Sciencelcsh:RM1-950Macular degenerationmedicine.diseaseeye diseasesSurgerylcsh:Therapeutics. PharmacologyDelayed-Action Preparations030221 ophthalmology & optometryBranch retinal vein occlusionsense organsbusiness030217 neurology & neurosurgeryDrug Design, Development and Therapy
researchProduct

Medición de circunferencias en el fleboedema

2010

La medición de circunferencias en diferentes puntos de referencia y en ambos miembros inferiores, permite advertir edemas de poco volumen. Además, permite valorar el efecto de la aplicación de determinados tratamientos.

3213.11 Ciències MédiquesFisioterapiaexploración clínicainsuficiencia venosacircunferenciasfleboedemaFisioterapia3213.11- Farmacia Medicina
researchProduct

Palpación en la insuficiencia venosa

2010

La palpación en la insuficiencia venosa permite valorar: el trayecto endurecido y/o dilatado de las venas, la temperatura cutánea y la consistencia del edema.

3213.11 Ciències MédiquesFisioterapiaexploración clínicainsuficiencia venosapalpaciónfleboedemadilatación varicosaFisioterapia3213.11- Farmacia Medicina
researchProduct

Drenaje linfático manual (DLM): manipulaciones básicas

2010

Las manipulaciones básicas del drenaje linfático manual son: el círculo fijo, el bombeo, el movimiento dador y el giro. Éstas presentan diferentes variantes y pueden combinarse entre sí.

3213.11 Ciències MédiquesFisioterapialinfedemadrenaje linfático manualmanipulaciones básicasFisioterapia3213.11- Farmacia Medicina
researchProduct

Tratamiento postural y respiración en el linfedema

2010

El postural en declive representa el medio más sencillo de reducir la presión venolinfática, favoreciendo así la reabsorción y el trasporte del líquido intersticial. Además, es el postural indicado para la aplicación de otras medidas de tratamiento como las respiraciones o el drenaje linfático manual.

3213.11 Ciències MédiquesFisioterapialinfedemaposturalrespiración abdominodiafragmática y torácicaFisioterapia3213.11- Farmacia Medicina
researchProduct

Presoterapia neumática en el linfedema

2010

En el caso de un linfedema de miembro superior, y su abordaje fisioterápico mediante presoterapia neumática los pasos a seguir son: 1) valoración previa; 2) preparación del miembro; 3) colocación del manguito y el postural; y 4) programación de parámetros regulables. Es recomendable que la sesión de presoterapia sea precedida por el drenaje linfático manual, e integrada en el tratamiento complejo descongestivo indicado en el linfedema.

3213.11 Ciències MédiquesFisioterapialinfedemapresoterapia neumáticamiembro superiorFisioterapia3213.11- Farmacia Medicina
researchProduct

Anorectal malformations and pregnancy-related disorders: a registry-based case-control study in 17 European regions

2013

Objective To identify pregnancy-related risk factors for different manifestations of congenital anorectal malformations (ARMs).Design A population-based case-control study.Setting Seventeen EUROCAT (European Surveillance of Congenital Anomalies) registries, 1980-2008.Population The study population consisted of 1417 cases with ARM, including 648 cases of isolated ARM, 601 cases of ARM with additional congenital anomalies, and 168 cases of ARM-VACTERL (vertebral, anal, cardiac, tracheo-esophageal, renal, and limb defects), along with 13371 controls with recognised syndromes or chromosomal abnormalities.Methods Multiple logistic regression analyses were used to calculate adjusted odds ratios …

ANOMALIESaetiologyMaternalLogistic regressionAnus ImperforateEpilepsyPre-EclampsiaMEDICATION USEPregnancyRisk FactorsOdds RatioAetiologymedia_commoneducation.field_of_studyObstetricsMATERNAL EXPOSUREObstetrics and GynecologyAnal atresiaCONGENITAL-MALFORMATIONSAnorectal MalformationsEuropeParityHuman Reproduction Renal disorder [NCEBP 12]Population studyFemaleAnal Atresiamedicine.medical_specialtyFeverReproductive Techniques Assistedmedia_common.quotation_subjectPopulationFertilityGenomic disorders and inherited multi-system disorders [IGMD 3]VACTERLmedicineanorectal malformations; anal atresia; birth defects; aetiology; maternal; pregnancy; VACTERLHumansAbnormalities MultipleBirth DefectseducationPregnancyEpilepsybusiness.industryRENACCase-control studyInfant NewbornAbortion InducedOdds ratioBIRTH-DEFECTS PREVENTIONBECKWITH-WIEDEMANN-SYNDROMEHuman Reproducion Genomic disorders and inherited multi-system disorders [NCEBP 12]Estados de Saúde e de Doençamedicine.diseasePregnancy Complicationsmaternalbirth defectsEvaluation of complex medical interventions [NCEBP 2]Case-Control StudiesRISK-FACTORSPregnancy TwinMULTIPLE BIRTHSbusinessIN-VITRO FERTILIZATION
researchProduct